MedPath

CIPROFLOXACIN INJECTION USP

CIPROFLOXACIN INJECTION USP

Discontinued
DIN Number

02256789

Drug Class

Human

Market Date

Mar 12, 2007

Company
HC

Sandoz Canada, Inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02256789
AIG Number0123207003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J01MA02 CIPROFLOXACIN
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification08:12.18
Health Canada Classification

ACTIVE INGREDIENTS (1)

CIPROFLOXACINActive
Strength: 10 MG / ML
Monograph: CIPROFLOXACIN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.